US Biologic today announced that Dr. Jolieke G. van Oosterwijk, Chief Scientific Officer, will present at the World Vaccine Congress Washington 2022 in Washington, D.C. on Wednesday, April 20, 2022 , at 3:25 p.m. ET.
| MEMPHIS, Tenn., April 18, 2022 /PRNewswire/ -- US Biologic today announced that Dr. Jolieke G. van Oosterwijk, Chief Scientific Officer, will present at the World Vaccine Congress Washington 2022 in Washington, D.C. on Wednesday, April 20, 2022, at 3:25 p.m. ET.
Surveillance is not the last step to prevent pandemics that can cost millions of lives and trillions in economic damage. Dr. van Oosterwijk will speak on “Using zoonotic disease surveillance to guide oral vaccine design” and will present the methods US Biologic uses to effectively prevent pandemic-level diseases at first surveillance. “Surveillance is an essential first step,” van Oosterwijk says, “But it’s not the last step to prevent pandemics that can cost millions of lives and trillions in economic damage.” In the presentation, Dr. van Oosterwijk will connect effective surveillance, rapid vaccine design, manufacturing, and application, as well interactions between complementary animal and human vaccination campaigns. “Seventy-five percent of all emerging infectious disease start with animals,” says David Sanders, Executive Director of Securing America’s Medicines and Supply (SAMS), of which US Biologic is a member. “US Biologic’s oral-delivery platform provides an essential toolkit to protect American health and security. How else are we going to prevent the next animal-borne pandemic?” About US Biologic: Aspire. Innovate. Deliver.
SOURCE US Biologic, Inc. |
View original content to download multimedia:
